Agreed, and the funds would be better spent on Stage two cancer trials Covid trials and point 4) here
● PharmAust identifies optimum monepantel (MPL) drug plasma range for treatment of
pet dogs with B cell lymphoma
● Retrospective data analysis of the phase 2 trial shows the combination of MPL +
prednisolone more than doubling life expectancy of pet dogs compared with standardof-care (prednisolone alone2)
● With the prohibitive pricing of canine chemotherapy PharmAust believes that subject to
phase 3 results, MPL could be commercially compelling
● PharmAust will seek input for the phase 3 trial from potential licensing partners
● Further benefit of the MPL combination treatment was pet owners reported very high
quality of life for their dogs
● PharmAust is planning for additional phase 3 trial sites in New Zealand and the US
If PAA can put some more runs on the board everything else will follow.
All that aside. Great Announcement. Starting to feel like we are starting to get some traction.
- Forums
- ASX - By Stock
- PAA
- Ann: Following Extension of Survival, PAA Prepares Phase 3 Trial
Ann: Following Extension of Survival, PAA Prepares Phase 3 Trial, page-33
-
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.55M |
Open | High | Low | Value | Volume |
19.5¢ | 19.5¢ | 18.5¢ | $330.4K | 1.741M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4071 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.5¢ | 24580 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4071 | 0.190 |
12 | 453603 | 0.185 |
14 | 471449 | 0.180 |
8 | 743200 | 0.175 |
4 | 115882 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 346149 | 3 |
0.205 | 55141 | 4 |
0.210 | 300000 | 2 |
0.215 | 459058 | 6 |
0.220 | 239679 | 2 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online